Dr. Reddy's Laboratories Newsroom

Dr Reddy's Labs Is Maintained at Overweight by Barclays

Dow JonesNov 6 22:38

Dr Reddy's Laboratories Analyst Ratings

BenzingaNov 6 22:25

Barclays Maintains Dr. Reddy's Laboratories(RDY.US) With Buy Rating, Cuts Target Price to $17

Futu NewsNov 6 16:31

Jefferies Adjusts Dr. Reddy's Laboratories' Price Target to INR1,130 From INR1,120, Keeps at Underperform

MT NewswiresNov 6 15:16

Dr Reddy's Laboratories Analyst Ratings

BenzingaJul 30 19:42

BofA Securities Maintains Dr Reddy's Laboratories Ltd(RDY.US) With Buy Rating

Futu NewsJul 29 22:32

Barclays: Maintaining the Dr. Reddy's Laboratories (RDY.US) rating, adjusted from an increase to an increase rating, and the target price was adjusted from $80.00 to $81.00.

Zhitong FinanceMay 9 02:50

Dr Reddy's Laboratories Analyst Ratings

BenzingaMay 9 02:50

Barclays Maintains Overweight on Dr Reddy's Laboratories, Raises Price Target to $81

BenzingaMay 9 02:50

Dr Reddy's Laboratories Analyst Ratings

BenzingaJan 29 20:09

Barclays Adjusts Price Target on Dr. Reddy's Laboratories to $70 From $67, Maintains Overweight Rating

MT NewswiresJun 1, 2023 21:37

Barclays Adjusts Price Target on Dr. Reddy's Laboratories to $66 From $69, Reiterates Overweight Rating

MT NewswiresOct 25, 2022 19:10